Prostate Specific Antigen Nadir After Radical Cystoprostatectomy in Patients With Benign Prostatic Tissue: A Benchmark To Define Biochemical Recurrence after Radical Prostatectomy.

MLA

Hosseini, Seyed Yousef, et al. “Prostate Specific Antigen Nadir After Radical Cystoprostatectomy in Patients With Benign Prostatic Tissue: A Benchmark To Define Biochemical Recurrence after Radical Prostatectomy.” Urology Journal, vol. 16, no. 6, Dec. 2019, pp. 563–66. EBSCOhost, https://doi.org/10.22037/uj.v0i0.4551.

APA

Hosseini, S. Y., Alemi, M., Amini, E., & Riazi, N. (2019). Prostate Specific Antigen Nadir After Radical Cystoprostatectomy in Patients With Benign Prostatic Tissue: A Benchmark To Define Biochemical Recurrence after Radical Prostatectomy. Urology Journal, 16(6), 563–566. https://doi.org/10.22037/uj.v0i0.4551

Chicago

Hosseini, Seyed Yousef, Mohsen Alemi, Erfan Amini, and Naser Riazi. 2019. “Prostate Specific Antigen Nadir After Radical Cystoprostatectomy in Patients With Benign Prostatic Tissue: A Benchmark To Define Biochemical Recurrence after Radical Prostatectomy.” Urology Journal 16 (6): 563–66. doi:10.22037/uj.v0i0.4551.